A Rare Case of Frequent Ventricular Fibrillation After MitraClip Therapy: Nursing Strategies for Success
Abstract
Mitral regurgitation (MR) is a common valvular heart disease and is associated with a high-surgical risk for older or comorbid patients. MitraClip therapy, a percutaneous mitral valve repair method, provides a safe and effective alternative to open-heart surgery and has been validated in real-world settings. To date, critical care nursing experience for MitraClip therapy remains limited. We aimed to present and discuss the critical care nursing experience of a patient with frequent ventricular fibrillation (VFiB) after MitraClip therapy. Case study. We reviewed and retrieved the necessary information from the medical records. A 73-year-old man with severe MR who underwent MitraClip therapy was transferred to the Cardiovascular Intensive Care Unit (CICU) and experienced three episodes of frequent VFiB within 72 h. He required standard cardiopulmonary resuscitation (CPR) and nine unsynchronised defibrillations of 150 J, along with blood pressure support (norepinephrine), potassium supplementation, anti-infection medication (ceftriaxone and levofloxacin), anticoagulant therapy (clopidogrel and enoxaparin sodium) and nutritional support (albumin and enteral nutrition). The patient finally restored sinus rhythm, was extubated, and after 5 days in the CICU, was transferred to the general cardiology ward. Effective treatment and qualified nursing care, including the application of emergency interventions, correction of the possible causes of frequent VFiB, administration of…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.